ニュース
ニュース2026.5.28
University of California, BerkeleyのFulbright Global Scholar、Jared Mazzanti先生が来訪されました
2026年4月13日~5月22日、東北大学病院未来医療ヘルスケアデザインプログラムにて、Fulbright Global Scholarに選出された、University of California, Berkeley(UCB)School of Public Health. Director of Strategic Initiatives, Office of the DeanのJared Mazzanti先生をお迎えしました。フルブライト・プログラムは、単なる留学奨学金ではなく、「相互理解を通じて世界の平和と協力を促進する」ことを目的とした、米国を代表する国際交流プログラムです。選考では、学術的な実績だけでなく、リーダーシップや公共性、国際協調性、そして将来社会にどのような影響を与える人物かが重視され、修了者は世界各国で大学・行政・研究・産業界などのリーダーとして活躍しており、分野や国境を越えた国際的な人的ネットワークを形成している点も大きな特徴です。
Mazzanti先生は15年以上にわたり、UCB、Harvard T.H. Chan School of Public Health、Peking Universityなどにおいて、学術界とビジネスをつなぐ領域で活躍されてきました。UCBでは学長室勤務を経て、公衆衛生大学院の戦略イニシアチブ担当として、研究者、業界パートナー、投資家、卒業生、政策立案者をつなぐ連携基盤の構築に従事されています。また、助成金やアクセラレーションプログラムの設計、特にアジア地域に重点を置いた国際協力ネットワークの構築にも取り組まれています。
今回の本学訪問では、「日本、インド、韓国のヘルスケア・医療機器イノベーション環境の比較」をテーマに、本学を含めアカデミアの経営層や有識者、官公庁、ヘルスケア領域の国内企業経営層、ベンチャーキャピタルの多くのみなさまにお時間をいただき、面談・インタビューを実施しました。
また、5月13日には、大学のアカデミアが国内外でイノベーションエコシステムを通じていかに世界にインパクトを与えうるかをテーマとしたオンラインセミナーを開催し、学内外の120名を超える参加者に向けてご講演いただきました。
本訪問を通じて構築されたネットワークを基盤に、今後の国際共同研究や産学連携のさらなる発展が期待されます。
University of California, Berkeley Fulbright Global Scholar, Jared Mazzanti Visits Tohoku University Hospital
From April 13 to May 22, 2026, Tohoku University Hospital Future Medical and Healthcare Design Program welcomed Jared Mazzanti, Director of Strategic Initiatives, Office of the Dean at University of California, Berkeley School of Public Health, as a Fulbright Global Scholar.
The Fulbright Program is not merely a study abroad scholarship, but one of the United States’ leading international exchange programs, established to promote global peace and cooperation through mutual understanding. Selection is based not only on academic excellence, but also on leadership, public-mindedness, international collaboration, and the potential to create meaningful societal impact. Fulbright alumni have gone on to serve as leaders in academia, government, research, and industry around the world, forming influential international networks that transcend disciplines and national borders.
For more than 15 years, Mr. Mazzanti has worked at the intersection of academia and business at institutions including University of California, Berkeley, Harvard T.H. Chan School of Public Health, and Peking University. Following his service in the Chancellor’s Office at UCB, he has been leading strategic initiatives at the School of Public Health, where he works to build collaborative networks connecting researchers, industry partners, investors, alumni, and policymakers. He is also engaged in designing grant and acceleration programs, as well as fostering international collaboration networks with a particular focus on Asia.
During his visit to Tohoku University, Mr. Mazzanti conducted interviews and meetings with university leadership and experts, government officials, healthcare industry executives, and venture capital stakeholders, including members of Tohoku University, under the theme of “Comparative Analysis of Healthcare and Medical Device Innovation Ecosystems in Japan, India, and South Korea.”
In addition, on May 13, he delivered an online seminar on how academic institutions can create global impact through domestic and international innovation ecosystems. The seminar attracted more than 120 participants from both within and outside the university.
The networks established through this visit are expected to serve as a foundation for future international collaborative research and further advancement of academia-industry partnerships.

April 21, 2026 – Visit to the University Headquarters
(From left: Hideo Harigae, Executive Vice President; Teiji Tominaga, President of Tohoku University; Dr. Jared Mazzanti; Atsuhiro Nakagawa, Vice Executive Vice President; and Takafumi Aoki, Executive Vice President)

(左から長濵勉投資部長、中森文洋投資部Vice President、Jared Mazzanti先生、佐藤耕司代表取締役社長)
April 21, 2026 – Visit to Tohoku University Venture Partners
(From left: Tsutomu Nagahama, General Manager, Executive Officer of Investment Department; Fumihiro Nakamori, Vice President of Investment Department; Dr. Jared Mazzanti; and Koji Sato, President and CEO)

April 23, 2026 – From left: Atsuhiro Nakagawa, Director of the Biodesign Division; Naoto Ishii, Dean, Graduate School of Medicine and School of Medicine; and Dr. Jared Mazzanti

May 18, 2026 – Ms. Marrie-Pierre Favre, Chief Global Officer

May 19, 2026 – With the staff of the Industry-Academia Collaboration Office and the Biodesign Division
